Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mona Bafadhel

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
The Lancet. Respiratory Medicine|November 18, 2017
Eosinophils in COPD: are we nearly there yet?Mona Bafadhel
The Lancet. Respiratory Medicine|September 21, 2018
Symptomatic COPD: is it time for triple therapy?Mona Bafadhel
The Lancet. Respiratory Medicine|May 15, 2021
Inhaled budesonide for early treatment of COVID-19 - Authors' replySanjay Ramakrishnan, Mona Bafadhel
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 5, 2021
Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?Sanjay Ramakrishnan, Mona Bafadhel
The European Respiratory Journal|January 25, 2020
Is it time to give up on "self-management" of COPD exacerbations?Sanjay Ramakrishnan, Mona Bafadhel
The European Respiratory Journal|March 7, 2020
The CICERO (Collaboration In COPD ExaceRbatiOns) Clinical Research CollaborationWim Janssens, Mona Bafadhel, , et al.
The Lancet. Respiratory Medicine|January 1, 2022
Heterogeneity of IPF exacerbationsSanjay Ramakrishnan, Mona Bafadhel
The Journal of Allergy and Clinical Immunology|September 5, 2013
Exhaled nitric oxide and blood eosinophilia: independent markers of preventable riskIan D Pavord, Mona Bafadhel
The Lancet. Respiratory Medicine|August 3, 2020
Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?Dan V Nicolau, Mona Bafadhel
Respirology (Carlton, Vic.)|April 4, 2017
Alternatives to induced sputum for identifying inflammatory subtypes of asthmaJodie L Simpson, Mona Bafadhel
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
The Lancet. Respiratory Medicine|November 18, 2017
Eosinophils in COPD: are we nearly there yet?Mona Bafadhel
The Lancet. Respiratory Medicine|September 21, 2018
Symptomatic COPD: is it time for triple therapy?Mona Bafadhel
The Lancet. Respiratory Medicine|May 15, 2021
Inhaled budesonide for early treatment of COVID-19 - Authors' replySanjay Ramakrishnan, Mona Bafadhel
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 5, 2021
Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?Sanjay Ramakrishnan, Mona Bafadhel
The European Respiratory Journal|January 25, 2020
Is it time to give up on "self-management" of COPD exacerbations?Sanjay Ramakrishnan, Mona Bafadhel
The European Respiratory Journal|March 7, 2020
The CICERO (Collaboration In COPD ExaceRbatiOns) Clinical Research CollaborationWim Janssens, Mona Bafadhel, , et al.
The Lancet. Respiratory Medicine|January 1, 2022
Heterogeneity of IPF exacerbationsSanjay Ramakrishnan, Mona Bafadhel
The Journal of Allergy and Clinical Immunology|September 5, 2013
Exhaled nitric oxide and blood eosinophilia: independent markers of preventable riskIan D Pavord, Mona Bafadhel
The Lancet. Respiratory Medicine|August 3, 2020
Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?Dan V Nicolau, Mona Bafadhel
Respirology (Carlton, Vic.)|April 4, 2017
Alternatives to induced sputum for identifying inflammatory subtypes of asthmaJodie L Simpson, Mona Bafadhel
Pageof 15